An interventional study of positive expiratory pressure in Hip Fractures (ICD-10 72.01-72.2), sponsored by University Hospital Bispebjerg and Frederiksberg. Recruiting at 2 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-23.
Sponsored by University Hospital Bispebjerg and Frederiksberg · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 57 studies in Hip Fractures with a site in Denmark — 8 open to participants now, 10 under way, none of them phase 3. Hip Fractures · Denmark.
Among the 57 studies in Hip Fractures with a site in Denmark, this one is the 5th largest by planned enrollment of the 45 interventional ones that give a count, is one of 4 that started in 2024, is one of 22 with no phase, and was the 55th registered.
843 studies on the registry are indexed under Hip Fractures; 166 are open to participants now.
Browse Hip Fractures studies →8 of the 57 studies in Hip Fractures with a site in Denmark are open now. Recruiting first, the newest first:
Peter Gaarsdal Uhrbrand · Sites in Denmark
Ages 65+
Odense University Hospital · Sites in Denmark
Ages 18–65
Soren Overgaard · Sites in Denmark
Ages 65+
University of Aarhus · Sites in Denmark
Ages 75+
Lolland Community, Denmark · Sites in Denmark
Ages 65+
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 104 Hip Fractures studies recruiting now, 82 (79%) set no upper age limit and 6 (6%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
57 studies; the count open now beside each. This study's row is marked.
First in 1995; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 566 is above the median of 86 across 534 interventional studies indexed under Hip Fractures.
Median enrollment 90 across the 45 interventional studies, 230 across the 12 observational. Of the 39 that completed or were terminated, 2 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 57 have an industry lead sponsor. The 10 most frequent:
University Hospital Bispebjerg and Frederiksberg is the lead sponsor of 70 studies on the registry; 17 are open to participants now.
University Hospital Bispebjerg and Frederiksberg has 2 studies filed under Hip Fractures — fewer than ten, so there is no comparison to draw.
4 of the studies in Hip Fractures with a site in Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06938789University of AarhusHow Bleeding Affects Delirium in Older Patients With Hip Fractures: The IMPROVE-HIP Study | 2026-12-31 |
| NCT07867899Peter Gaarsdal UhrbrandDexmedetomidine for Prevention of Delirium After Hip Fracture Surgery | 2027-03-31 |
| NCT04796350AgNovos Healthcare, LLCRESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | 2027-04-01 |
| NCT06898814Soren OvergaardThe Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery | 2027-06-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 57 studies in Hip Fractures with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to investigate whether pre- and postoperative treatment with systematic PEP therapy can prevent hospital-acquired pneumonia in patients with hip frac-ture. It will also learn about the barriers regarding PEP therapy in this group of patients.
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
For patients with e.g. dementia or brain injury, the ability to give informed consent will be assessed individually.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Medical therapy device
Device: positive expiratory pressure
Standard treatment
PEP therapy
The incidence of hospital-acquired pneumonia
Primary Outcome is the incidence of hospital-acquired pneumonia in the control and intervention group. Documented in the Sundhedsplatformen and diagnosed with one ore more of the following: * Thoracic x-ray * Sputum culture * Auscultation * Infection markers
Time frame: During hospitalization, from intervention start to discharge, which is on average one week
Number of participants dead within 30-days after discharge
Number of participants dead within 30 days after discharge
Time frame: 30-day mortality, assessed 30 days after discharge from the orthopedic ward
Number of participants readmitted within 30-days after discharge
Number of participants readmitted within 30 days after discharge
Time frame: 30-day readmission post-discharge, assessed 30 days after discharge from the orthopedic ward
Incidence of delirium during hospitalization (journal entry, CAM-screening, diagnosis), up to 4 weeks.
Incidence of delirium during hospitalization (journal entry, CAM-screening, diagnosis), up to 4 weeks.
Time frame: During hospitalization, from intervention start to discharge, which is on average one week
Degree of regained basic mobility (Cumulated Ambulation Score - CAS) on the the day of discharge compared to the assement made at admission.
Degree of regained basic mobility (Cumulated Ambulation Score - CAS) on the the day of discharge compared to the assement made at admission. CAS values ranges from 0 to 6. A score of 6 represents an independant patient in regards to getting in and out of bed, sit-to-stand from a chair, and walking. A score of 0 represents a patient completely dependant on help getting in and out of bed, sit-to-stand from a chair, and walking.
Time frame: CAS the weeks up to hip fracture and CAS at discharge, which is on average one week after admission
Discharge destination (home, nursing home, care facility, rehab, another ward/hospital, etc.). Number of participants discharged to home, care facility, rehab, another hospital/ward or ot he discharge destination.
Discharge destination (home, nursing home, care facility, rehab, another ward/hospital, etc.). Number of participants discharged to home, care facility, rehab, another hospital/ward or o the discharge destination.
Time frame: Assessed at discharge from the orthopedic department, which is on average one week efter admission
Plan to share: Yes — Access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), will be provided to anyone who wishes to access the data.
Supporting information: Study protocol, Statistical analysis plan
No publications or documents are linked to this record.
Started Feb 2024 (actual). Primary completion is estimated for Dec 2029, 70 months after the start.
Of 221 non-industry interventional studies with no phase under Hip Fractures, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 55. This study's planned 70 months is above that.
Counting every sponsor, half of 237 studies reached it within 29 months; a quarter within 10 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital Bispebjerg and Frederiksberg